1350473-39-0 Usage
Structure
Piperidine ring and amine group
Usage
Synthesis of pharmaceuticals, building block in organic chemistry
Research potential
Drug candidate for neurological and psychiatric disorders
Precursor role
Production of various compounds, including potential new drugs and industrial materials
Molecular structure
Unique, contributing to specific properties and reactivity
Versatility
Important chemical in various fields of science and industry
Check Digit Verification of cas no
The CAS Registry Mumber 1350473-39-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,5,0,4,7 and 3 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1350473-39:
(9*1)+(8*3)+(7*5)+(6*0)+(5*4)+(4*7)+(3*3)+(2*3)+(1*9)=140
140 % 10 = 0
So 1350473-39-0 is a valid CAS Registry Number.
1350473-39-0Relevant articles and documents
INHIBITORS OF CYCLIN DEPENDNT KINASE 7 (CDK7)
-
Paragraph 240, (2018/02/28)
The present invention provides novel compounds of Formula (I) and pharmaceutically acceptable salts, solvates, hydrates, tautomers, stereoisomers, isotopically labeled derivatives, and compositions thereof. Also provided are methods and kits involving the compounds or compositions for treating or preventing proliferative diseases (e.g., cancers (e.g., leukemia, melanoma, multiple myeloma), benign neoplasms, angiogenesis, inflammatory diseases, autoinflammatory diseases, and autoimmune diseases) in a subject. Treatment of a subject with a proliferative disease using a compound or composition of the invention may inhibit the aberrant activity of cyclin-dependent kinase 7 (CDK7), and therefore, induce cellular apoptosis and/or inhibit transcription in the subject.
